From: SYT7 acts as an oncogene and a potential therapeutic target and was regulated by ΔNp63α in HNSCC
Features | No. of patients | SYT7 expression | p value | |
---|---|---|---|---|
Low | High | |||
All patients | 60 | 27 | 33 | |
Age (years) | 0.737 | |||
≤ 64 | 31 | 14 | 17 | |
> 64 | 27 | 11 | 16 | |
Gender | 0.486 | |||
Male | 28 | 11 | 17 | |
Female | 31 | 15 | 16 | |
Grade | < 0.001*** | |||
1 | 22 | 18 | 4 | |
2 | 28 | 6 | 22 | |
3 | 7 | 0 | 7 | |
Tumor size (cm) | 0.757 | |||
< 2.5 | 22 | 8 | 14 | |
≥ 2.5 | 27 | 11 | 16 | |
Lymph node positive | 0.129 | |||
= 0 | 25 | 13 | 12 | |
> 0 | 9 | 2 | 7 | |
Lymphatic metastasis (N) | 0.129 | |||
N0 | 25 | 13 | 12 | |
N1 | 9 | 2 | 7 |